Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F. Griesinger
OA12.01 Phase II Data for the MET Inhibitor Tepotinib in Patients With Advanced NSCLC and MET Exon 14-Skipping Mutations
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
65P NEOliquid: Detection of KIF5B–RET Fusions in Liquid Biopsy Samples
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PL02.03 Brigatinib vs Crizotinib in Patients With ALK Inhibitor-Naive Advanced ALK+ NSCLC: First Report of a Phase 3 Trial (ALTA-1L)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-28 Impact of Afatinib Dosing on Safety and Efficacy Real-World in Patients With EGFR Mutation-Positive Advanced NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.12-04 Liposomal Irinotecan vs Topotecan in Patients With Small Cell Lung Cancer Who Have Progressed on/After Platinum-Based Therapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-82 Risk of Not Receiving 2nd Line Therapy Is High in EGFR Mt+ Pts: Real World Data of Certified Lung Cancer Centers on Treatment Sequence in EGFR Mt+ PTS
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Managing Individuals With Propensity to Myeloid Malignancies Due to Germline RUNX1 Deficiency
Haematologica
Hematology
Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors
Oncologist
Cancer Research
Medicine
Oncology
Prospective Multicenter Registry for Secondary CNS Involvement in Malignant Lymphoma: An Update With Data From 181 Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology